Naturo Agrotech India Limited posted nil revenue for the half-year ending September 2025, swinging to a net loss of Rs 19.55 lakh. The results come under scrutiny as statutory auditors issued a qualified opinion, flagging issues including unverifiable inventory, questionable loan recoverability, and non-compliance with the Companies Act.
Naturo Agrotech Reports Nil Revenue and Qualified Auditor Opinion
Revenue: Rs 0.00 Lakh (vs Rs 1338.64 Lakh in H1 FY24); Net Loss: Rs 19.55 Lakh.
Reader Takeaway: Extreme caution advised; nil revenue combined with severe auditor concerns regarding asset recoverability and governance pose significant risks.
What just happened
Naturo Agrotech India Limited released its financial results for the half-year ended September 30, 2025, revealing a complete halt in operational revenue. The company reported a net loss of Rs 19.55 lakh, a sharp reversal from the Rs 49.31 lakh profit recorded in the same period last year. Total expenses stood at Rs 19.55 lakh.
Why this matters
The statutory auditor has issued a qualified opinion, signaling deep concerns over the company's financial health. Key red flags include loans and advances totaling Rs 55.22 crore granted without proper compliance under the Companies Act, and inventory worth Rs 10.65 crore that lacks physical verification reports. These issues cast doubt on the accuracy of the company’s balance sheet.
Risks to watch
Investors should be wary of the auditor's uncertainty regarding the recoverability of Rs 14.68 crore in trade receivables, as no confirmations were received from debtors. Additionally, the auditor highlighted non-payment of statutory dues (TDS/TCS) and the absence of an 'edit log' in the accounting software, which severely limits the ability to verify financial transaction integrity.
What to track next
The company's ability to provide evidence for its asset valuations and its success in resolving statutory non-compliance are the primary factors to monitor. The management's response to the auditor’s grave observations will be critical in determining the future direction of the stock.
